---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-118073"
form_type: "8-K"
ticker: null
cik: "0001808158"
company_name: "Repare Therapeutics Inc."
filed_at: "2024-04-26T23:59:59+00:00"
generated_at: "2026-06-03T06:38:34.830631+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Repare Therapeutics appoints Steven H. Stein to board; Todd Foley not seeking re-election

## Summary
- Todd Foley will not stand for re-election as Class I director at June 17, 2024 annual meeting after 7+ years.
- Steven H. Stein, M.D., appointed as Class II director effective June 2024 annual meeting.
- Dr. Stein is Chief Medical Officer of Incyte Corporation; joins Science & Technology Committee.
- Stein will receive option to purchase 54,400 common shares under standard non-employee director compensation.

## SEC filing metadata
- accession: 0001193125-24-118073
- form_type: 8-K
- cik: 0001808158
- company_name: Repare Therapeutics Inc.
- filed_at: 2024-04-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/d798198d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-118073
- JSON: https://secwatch.observer/filing/0001193125-24-118073.json
- Plain text: https://secwatch.observer/filing/0001193125-24-118073.txt

## Key facts
- Executive change
  Steven H. Stein was appointed as Class II Director at Repare Therapeutics Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On April 25, 2024, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed Steven H. Stein, M.D. to serve as a Class II director of the Company, effective as of the Annual Meeting Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm
- Executive change
  Todd Foley departed as Class I Director at Repare Therapeutics Inc..
  - Action: not stand for re-election
  - Role: Class I Director
  source text: On April 24, 2024, Todd Foley notified the board of directors (the “ Board ”) of Repare Therapeutics, Inc. (the “ Company ”) of his decision not to stand for re-election as a Class I director following the end of his current term on June 17, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.